MedPath

Preliminary investigation of contrast media dose for sequential diagnosis of cerebral MR perfusion and 3D-MR DSA at 3T MRI

Phase 4
Conditions
Brain tumor
Registration Number
JPRN-UMIN000009795
Lead Sponsor
Juntendo Univ.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

1) Contraindication of MRI 2) Allergy to Gd contrast media 3) Asthma 4) Severe renal disease 5) During pregnancy or lactation 6) Investigator make a judgmental decision as unsuitableness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Conduct a qualitative assessment of Perfusion MRI and 3DMR DSA
Secondary Outcome Measures
NameTimeMethod
CNR of gray matter and white matter SNR of gray matter and white matter Adverse drug reaction to the contrast agent
© Copyright 2025. All Rights Reserved by MedPath